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Hyperinsulinism secondary to peripheral insulin resistance 
has been described as the most frequent etiologic factor in 
cochlear and vestibular syndromes. Aim: This experimental 
study recorded and analyzed evoked auditory potential 
changes using transtympanic electrocochleography (EcochG) 
during induced acute hyperinsulinism in an animal model. 
Materials and Methods: Six adult male sheep were randomly 
divided into 2 groups. The animals were submitted to EcochG 
under general anesthesia, and a peripheral blood sample 
was collected to measure glycemia and insulinemia. Animals 
in the intervention group (n=3) received regular human 
insulin IV (0.1 U/kg). The control group (n=3) received 
saline solution. Glycemia and insulinemia were measured 
simultaneously with the recording of evoked potentials 
at 10-minute intervals during 90 minutes. Results: The 
intervention group experienced a progressive suppression 
in action potential amplitude when compared to the control 
group (p=0.001). Conclusion: Data strongly suggest that 
acute induced hyperinsulinism suppresses cochlear function. 
Results may be attributed to loss of Na+K+ATPase activity in 
the stria vascularis, leading to loss of endocochlear potential 
and subsequent depolarization of cochlear hair cells as well 
as of neural cells in the auditory portion of cranial nerve VIII.
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INTRODUCTION
Many experimental and clinical studies have de-
monstrated the effect of carbohydrate metabolism on 
inner ear function. Most of these studies have shown that 
hyperinsulinemia is the most frequent metabolic altera-
tion associated with cochleo-vestibular disease.1-6 D’Avila 
and Lavinsky studied the glucose profile of patients with 
Ménière’s disease and showed that 72% of these cases 
had variables degrees of hyperinsulinemia that could be 
detected by the 5-hour glucose tolerance test.7
Hyperinsulinemia is an early change in peripheral 
resistance to insulin.8,9 Although classified as a mild disor-
der, it may affect significantly the inner ear metabolism 
and fluid concentrations.10
The inner ear is not able to store much energy.11,12 
Paradoxically, it has a high metabolic activity, especially 
for maintaining endolymph ionic concentrations.13,14 
Mendelsohn and Roderique showed that induction of 
hypoglycemia in rodents reduces significantly endolymph 
potassium concentrations.15
Mangabeira-Albernaz and Fukuda have suggested 
that hyperinsulinemia could block (Na+/K+)-ATPase en-
zyme activity on the vascular stria,3 removing potassium 
from endolymph, retaining sodium, and thus increasing 
the osmotic pressure at this level.10
Disagreements about the true impact of metabolic 
disorders on the cochleo-vestibular system arise from 
the impossibility of observing histopathological changes 
in vivo.16 The purpose of this study was monitor the 
changes in evoked potentials by means of transtympanic 
electrocochleography (ECoG) during acute induction of 
hyperinsulinemia in sheep with the aim of understanding 
this association in greater depth.
MATERIAL AND METHOD
This experimental study was carried out in the 
facilities of the animal experimental unit of the research 
center of the institution. The Research Ethics Committee 
approved the study (registration number 04-070).
The sample size was based on the estimated di-
fference of at least 3.5 standard deviation units between 
groups; the alpha value was set at 0.05 and the statistical 
power of the study was defined as 80%.
Six adult male Corriedale sheep weighing from 40 
to 43 kg were randomly allocated to two equal groups 
(control and intervention groups). International guidelines 
for handling experimental animals were followed throu-
ghout the study.
 
Anesthesia
Animals required a 48-hour fasting period prior 
to anesthesia due to slow gastric emptying in ruminants.
Sedation was attained with 500 mg/kg acepro-
mazine (Univet, Sao Paulo, SP). Induction of anesthesia 
was done with 15 mg/kg intravenous sodium thiopental 
(Abbott, Rio de Janeiro, RJ) and maintained with the 
same drug by a continuous infusion pump (Nutrimat II, 
B.Braun, Sao Gonçalo, RJ) at 600 mg/hour, supervised by 
a veterinary doctor. Orotracheal intubation was done in 
all animals with an 8 or 9 mm tube (Fig. 1) coupled to a 
closed system anesthesia cart (Modulus 4000, Narcosul, 
Porto Alegre, RS) with 100% oxygen. Oxygen saturation, 
the heart rate (Biox 3700e, Ohmeda, Louisville, CO, EUA), 
the tidal volume, the respiratory frequency (Ventcare, São 
Paulo, SP), and the anal temperature were monitored.
Figure 1. Study animal during the experimentation phase.
 
Recording evoked potentials
Auditory evoked potentials were recorded using a 
Morpheu All-In-One system developed by Dolsch Biome-
dical (Porto Alegre, RS). These recordings were analyzed 
using the Clampfit 9.2 software developed by Axon Ins-
truments (Fig. 2).
The primary puncture electrode (Medelec Ltd) was 
inserted into the middle ear through a small tympanotomy; 
its tip touched the promontory. The secondary electrode 
was placed on the nasal mucosa.
A microphone located on the external acoustic me-
atus issued a positive polarity (condensation) 110 dBHL 
acoustic stimulus. Tested frequencies were 5, 6, 7, 8, 9 
and 10 kHz. Fifteen and 15.000 Hz filters were used. The 
acoustic signal was amplified 100,000 times; 500 stimuli 
were provided for each frequency, totaling 3,000 stimuli 
for each one of the 10 recording moments.
 
Glucose and insulin blood samples
Peripheral blood was taken by jugular puncture to 
measure blood glucose and insulinemia. Blood glucose 
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was measured using the enzymatic-colorimetric glucose-
oxidase (Labtest) method; insulinemia was measured with 
electrochemoluminescence immunoassays using Modular 
Analytics E170 (Roche) analyzers. All laboratory tests 
were carried out at the Clinical Pathology Laboratory of 
the institution.
 
Induction of acute hyperinsulinemia
Blood samples were taken before the intervention 
to measure blood glucose and insulinemia simultaneously 
with evoked potential recordings.
Study group animals (n=3) were given 0.1 U/kg in-
travenous regular insulin in 20 ml of saline. Control group 
animals (n=3) were given only 20 ml of saline. Evoked 
cochlear potentials were recorded every 10 minutes during 
1 hour and 30 minutes (90 minutes), totaling 10 data ga-
thering moments. At the same time, peripheral blood was 
taken to measure blood glucose and insulinemia curves.
 
Statistical analysis
The Statistical Package for the Social Sciences (SPSS) 
version 12.0 software was used for data analysis. Baseline 
data (gathered at time zero) of the two groups were com-
pared applying the Student t test for independent samples. 
Analysis of Variance (ANOVA) for repeated samples was 
applied to assess amplitude changes in the cochlear action 
potential (AP) and blood glucose levels. Recordings of the 
cochlear action potential (AP) were presented as folds, 
the ratio of values observed at different moments from 
baseline measurements. The software SigmaPlot version 
8.0 was used to prepare the graphic presentation of results.
The significance level was defined as p < 0.05. 
RESULTS
There were no losses during the experimentation 
phase. Animals were extremely docile throughout the 
experimentation phases, which facilitated anesthetic and 
surgical instrumentation.
Recovery from anesthesia in the research center 
took on average 2 hours, after which the animals were 
transported to their origin under the care of the supplier.
Hyperinsulinemia and hypoglycemia were effecti-
vely induced (Figs. 3 and 4). Figure 3 shows the relation 
between mean blood glucose levels during the experiment 
and the mean amplitude of the cochlear AP in both groups.
Baseline data for both groups were similar in ter-
ms of insulinemia, blood glucose, and amplitude of the 
cochlear AP (respective p values - 0.59, 0.14 and 0.11).
The ANOVA test for repeated measures of AP 
amplitudes revealed that the intervention groups had 
a significant decrease in the amplitude of the cochlear 
PA compared to the control group (p=0.001). Figure 5 
shows the tracings belonging to one of the intervention 
animals, showing the progression of the amplitude across 
90 minutes.
Figure 2. Interface of the Clampfit 9.2 software.
Figure 3. Relation between cochlear action potential amplitude and 
blood glucose levels in both groups.
Figure 4. Mean blood insulin levels in the control and intervention 
groups.
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DISCUSSION
The research group has used sheep as experimen-
tal animals for otological surgical research and training 
since the last decade.17-20 Anatomical and morphometric 
similarities between sheep and human ears have been 
demonstrated.21 Structures are comparable in size to those 
of humans, which made it possible to use conventional 
anesthetic and surgical tools, without any adaptation.
Most of the success in handling these animals was 
the results of professional support by qualified and well-
trained veterinary doctors, based on their experience with 
previous protocols developed by the research group.
In this study, electrocochleography was applied 
to monitor the response to acute hyperinsulinemia. The 
literature contains no references about this method in she-
ep, making the present study a pioneering investigation 
in the context of this theme. The experience gained by 
the authors will enable other projects to be developed to 
assess other components of auditory evoked potentials, 
such as cochlear microphonism and the sum potential. A 
true mapping or scan was undertaken as the frequency 
spectrum at which stimulation would provide consistent 
responses was unknown; the frequencies chosen were 
those from 5 to 10 kHz. Thus, tone bursts, rather than 
broadband clicks (BBC), were chosen as the stimulus.
The idea that hyperinsulinemia is the first step in the 
development of peripheral insulin resistance (or glucose 
intolerance) has opened a vast field off research about its 
clinical repercussions. The negative impact of hyperinsu-
linemia on inner ear homeostasis is probably due to the 
ionic and metabolic features of the vascular stria, which is 
responsible for maintaining the endocochlear potential by 
secreting potassium into the endolymphatic space.
Our results revealed a much wider variation in blood 
insulin values compared to variation in blood glucose 
levels (Fig. 4), suggesting that the effects of exposure are 
secondary to hyperinsulinemia, and to a lesser degree, to 
hypoglycemia.
The predominant electrical response was a pro-
gressive decrease in the amplitude of the neural AP in 
the intervention group. Two mechanisms may explain 
this phenomenon:
• Hyperinsulinemia acts directly on auditory nerve 
fibers, compromising the ionic transport across the cell 
membrane and interrupting depolarization.
• Hyperinsulinemia acts on the vascular stria, com-
promising the maintenance of the endocochlear potential, 
thus interruption hair cell depolarization; this in turn affects 
subsequent depolarization of neural fiber cells.
We strongly believe that the neural effect we obser-
ved only reflects interference on cochlear activity secon-
dary to induced acute hyperinsulinemia. Recent studies by 
our group have shown that the cochlear activity in sheep, 
measured by distortion product otoacoustic emissions 
(DPOAE), decreased significantly after induction of acute 
hyperinsulinemia,17,18 suggesting a cochlear, rather than a 
neural, effect.
The theoretical mode that best explains our results is 
blockage of the (Na+/K+)-ATPase enzyme on the vascular 
stria, as suggested by Mangabeira-Albernaz and Fukuda.3 
This effect alters the ionic composition of endolymph, 
interrupting full depolarization of inner hair cells and of 
fibers comprising the auditory portion of the VIII cranial 
nerve.
Figure 5. Tracing of animals in the intervention group showing pro-
gressive reductions in the amplitude of cochlear action potentials.
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Lack of synchronism between the period of ma-
ximum hyperinsulinemia and the period of lowest AP 
amplitude may be explained theoretically by the fact that 
enzyme blockage has a somewhat delayed effect on en-
dolymphatic potassium concentrations; enough molecules 
remain to depolarize the cells in the first few minutes.
Insulin peripheral resistance and hyperinsulinemia 
have been studied in detail in a cardiovascular context, 
but are rarely associated with inner ear disorders. Studies 
undertaken by this and other groups3,17,18,22,23 have shown 
that inner ear disease may be interpreted as an early war-
ning sign for insulin resistance, justifying further clinical 
investigation in daily medical practice.
CONCLUSION
Our results demonstrated that induction of acute 
hyperinsulinemia results in marked changes in auditory 
function, evidenced by a decreased amplitude of the co-
chlear AP. These results may be attributed to suppression 
of (Na+/K+)-ATPase enzyme activity on the vascular stria, 
resulting in loss of the endocochlear potential and inter-
ruption of depolarization of fibers comprising the auditory 
portion of the VIII cranial nerve.
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